https://websites4-live-prod.ysmdevs.com/cancer/news-rss/?orgId=120592&title=Latest+News A selection of the latest research, academic, and other newsworthy developments at Center of Molecular and Cellular Oncology en-us Copyright 2026 Yale School of Medicine Thu, 14 May 2026 20:42:33 Z https://www.cancernetwork.com/view/novel-hp1k-inhibitor-shows-favorable-responses-in-ccrcc-solid-tumors https://www.cancernetwork.com/view/novel-hp1k-inhibitor-shows-favorable-responses-in-ccrcc-solid-tumors The HPK1 inhibitor NDI-101150 achieved “impressive” single-agent activity and a manageable safety profile as a monotherapy and in combination with pembrolizumab (Keytruda) among patients with advanced solid tumors, including clear cell renal cell carcinoma (ccRCC), in a phase 1/2 trial (NCT05128487) published in Cell Reports Medicine. Mon, 11 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/novel-drug-shows-promise-for-treating-advanced-kidney-cancer/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/novel-drug-shows-promise-for-treating-advanced-kidney-cancer/ A new immune therapy, which releases the immune system’s “brakes,” successfully treats a subset of patients with clear cell renal cell carcinoma. Thu, 07 May 2026 18:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/zaidi-awarded-trailblazer-cancer-research-grant/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/zaidi-awarded-trailblazer-cancer-research-grant/ Samir Zaidi, MD, PhD, was awarded an American Association for Cancer Research (AACR) Trailblazer Cancer Research Grant during the opening ceremony of the AACR annual meeting. Wed, 29 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ Yale Cancer Center faculty and trainees joined over 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in San Diego for the 117th American Association for Cancer Research (AACR) annual meeting. Thu, 23 Apr 2026 04:00:00 Z https://www.everydayhealth.com/cancer/metastatic-kidney-cancer-survival-rates/ https://www.everydayhealth.com/cancer/metastatic-kidney-cancer-survival-rates/ Other health issues may affect survival by changing what treatments you can have, says David Braun, MD, PhD, a medical oncologist and physician scientist at Yale Cancer Center in Connecticut. Fri, 10 Apr 2026 04:00:00 Z https://www.everydayhealth.com/cancer/care-options-for-metastatic-and-recurrent-renal-cell-carcinoma/ https://www.everydayhealth.com/cancer/care-options-for-metastatic-and-recurrent-renal-cell-carcinoma/ These medications most often treat advanced kidney cancers such as RCC, often in combination with immunotherapy. Targeted therapies work best for short-term needs, but they may not work as well long-term, says David Braun, MD, PhD, a medical oncologist and physician scientist at Yale Cancer Center in New Haven, Connecticut. Fri, 03 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-study-identifies-a-new-class-of-drug-targets-for-aggressive-leukemia/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-study-identifies-a-new-class-of-drug-targets-for-aggressive-leukemia/ Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer’s survival. If one component of the complex is deleted or removed, the cancer cells are sent into overdrive and die, finds a Yale-led study published Feb.10 in Science Signaling. Tue, 10 Feb 2026 19:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/drs-jan-bewersdorf-coraline-mlynarczyk-and-rubia-mancuso-receive-ash-scholar-awards/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/drs-jan-bewersdorf-coraline-mlynarczyk-and-rubia-mancuso-receive-ash-scholar-awards/ Jan Bewersdorf, MD, assistant professor of medicine (medical oncology and hematology), Coraline Mlynarczyk, PhD, assistant professor of medicine (medical oncology, hematology, and pathology), and Rubia Mancuso, PhD, postdoctoral associate, received American Society of Hematology (ASH) 2026 Scholar Awards. Wed, 28 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/standout-research-clinical-care-and-staff-support-recognized/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/standout-research-clinical-care-and-staff-support-recognized/ A dozen awards honored 15 people at January's Yale Cancer Center Annual Awards for work in 2025. Wed, 28 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/national-medical-honor-society-honors-yale-researchers/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/national-medical-honor-society-honors-yale-researchers/ The American Society of Clinical Investigation honors five Yale physician-scientists and their research Tue, 20 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-led-study-identifies-a-new-target-for-treating-acute-leukemia/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-led-study-identifies-a-new-target-for-treating-acute-leukemia/ B-cell acute lymphoblastic leukemia (B-ALL), the most common form of cancer in children and young adults, is vulnerable to an existing class of drugs that was previously developed for Alzheimer’s and Parkinson’s diseases. The findings, meaningful to all patients with leukemia but especially those who have relapsed, were published Jan. 8 in Nature Cancer. Thu, 08 Jan 2026 11:30:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-research-advances-presented-at-american-society-of-hematology-annual-meeting2025/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-research-advances-presented-at-american-society-of-hematology-annual-meeting2025/ Physicians, scientists, and trainees from Yale Cancer Center and Smilow Cancer Hospital attended the 67th annual meeting of the American Society of Hematology in Orlando, FL, December 6-9, 2025 to present the latest advances in hematological research and clinical care from Yale. Tue, 09 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/progress-and-hope-sharing-the-latest-advances-in-lung-cancer-care/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/progress-and-hope-sharing-the-latest-advances-in-lung-cancer-care/ On November 17, 2025, in honor of Lung Cancer Awareness Month, members of our Center for Thoracic Cancers at Smilow Cancer Hospital and Yale Cancer Center presented a patient forum: "Progress and Hope: Sharing the Latest Advances in Lung Cancer Care." The event was held in person at 55 Park Street in New Haven, CT. Tue, 18 Nov 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-develops-dual-action-vaccine-to-combat-aggressive-merkel-cell-carcinoma/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-develops-dual-action-vaccine-to-combat-aggressive-merkel-cell-carcinoma/ Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer, by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response, published Oct. 28 in Cell Reports. Tue, 28 Oct 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/ycc-publlications-2025/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/ycc-publlications-2025/ Publications regarding cancer attributed to first- and last-authors of published papers Mon, 27 Oct 2025 16:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/celebrating-50-years-yale-cancer-center/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/celebrating-50-years-yale-cancer-center/ YCC is celebrating a half century as an NCI-Designated Comprehensive Cancer Center Tue, 30 Sep 2025 04:00:00 Z https://www.cancernetwork.com/view/embracing-the-complexity-of-somatic-alterations-in-kidney-cancer-care https://www.cancernetwork.com/view/embracing-the-complexity-of-somatic-alterations-in-kidney-cancer-care In a conversation with CancerNetwork® during a visit to Yale Cancer Center in New Haven, Connecticut, David A. Braun, MD, PhD, detailed his group’s work in understanding how somatic alterations may impact responses or resistance to treatment among patients with kidney cancer. Mon, 22 Sep 2025 04:00:00 Z https://www.cancernetwork.com/view/considering-chemotherapy-and-improving-qol-in-mantle-cell-chemotherapy-care https://www.cancernetwork.com/view/considering-chemotherapy-and-improving-qol-in-mantle-cell-chemotherapy-care During a visit to Yale Cancer Center in New Haven, Connecticut, CancerNetwork® met with Shalin Kothari, MD, a Yale Cancer Center hematologist to discuss key considerations for tailoring therapeutic strategies to specific patients with mantle cell lymphoma (MCL) while preserving quality of life. Sun, 21 Sep 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/two-immunobiology-phd-students-have-been-awarded-the-ruth-l-kirschstein-predoctoral-individual-national-research-service-awards-f31/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/two-immunobiology-phd-students-have-been-awarded-the-ruth-l-kirschstein-predoctoral-individual-national-research-service-awards-f31/ Two Immunobiology PhD students, Sasha Tabachnikova, BA, and Lena Wirth, BS, have been awarded the prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Awards (F31) from the National Institutes of Health (NIH). F31 funding awards from the NIH are designed to help promising predoctoral students develop into productive, independent research scientists through mentored research training while conducting dissertation research. Fri, 19 Sep 2025 21:00:00 Z https://www.cancernetwork.com/view/navigating-immune-related-adverse-effects-during-kidney-cancer-therapy https://www.cancernetwork.com/view/navigating-immune-related-adverse-effects-during-kidney-cancer-therapy In a visit to Yale Cancer Center, CancerNetwork® spoke with Yale Cancer Center physician scientist Dr. David Braun about strategies for overcoming immune-related toxicities among patients undergoing treatment for renal cell carcinoma, and how these events may show prognostic potential in this population. Mon, 15 Sep 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/cancers-progress-detailed-by-3d-genomic-maps/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/cancers-progress-detailed-by-3d-genomic-maps/ Using new technology, Yale researchers examine cancer progression in single cells to visualize and understand its evolution from pre-cancerous to advanced disease in mouse models. Next steps include human tissue. Mon, 18 Aug 2025 10:00:00 Z https://www.cancernetwork.com/view/personalized-kidney-cancer-vaccines-provide-direction-to-immune-therapy https://www.cancernetwork.com/view/personalized-kidney-cancer-vaccines-provide-direction-to-immune-therapy Combining renal vaccines with immune therapy may better target tumor cells while limiting harm to healthy tissue, according to David A. Braun, MD, PhD. Tue, 29 Jul 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/drs-david-braun-and-sidi-chen-receive-cri-clip-and-technology-impact-awards/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/drs-david-braun-and-sidi-chen-receive-cri-clip-and-technology-impact-awards/ David Braun, MD, PhD, assistant professor of medicine (medical oncology and hematology) and a Louis Goodman and Alfred Gilman Yale Scholar, and Sidi Chen, PhD, associate professor of genetics and of neurosurgery, have been awarded 2025 Clinic & Laboratory Integration Program (CLIP) and Technology Impact Awards from the Cancer Research Institute (CRI). Thu, 17 Jul 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-researchers-develop-novel-antibody-rna-therapy-for-resistant-cancers/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-researchers-develop-novel-antibody-rna-therapy-for-resistant-cancers/ A modified antibody-RNA therapy gets by the defenses of hard-to-reach and hard-to-treat cancers. Wed, 16 Jul 2025 18:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/novel-insights-into-chromophobe-renal-cell-carcinoma-biology-and-potential-therapeutic-strategies/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/novel-insights-into-chromophobe-renal-cell-carcinoma-biology-and-potential-therapeutic-strategies/ Cancer fighting T cells, the immune system’s primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma and those that are present are indifferent to the tumor threat and traditional immune therapies, revealing the need for new targets and treatments. Wed, 02 Jul 2025 20:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/improving-cancer-outcomes-with-better-lynch-syndrome-testing-a-cost-benefit-study/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/improving-cancer-outcomes-with-better-lynch-syndrome-testing-a-cost-benefit-study/ A cost-benefit analysis of strategies for screening colorectal patients for Lynch syndrome (LS) found that either an optimized screening system, such as in place at YNHH, or upfront germline testing for all colorectal cancer patients would be better than the testing situation found in most institutions. Data shows that less than half of all CRC patients follow all the testing steps needed to determine if they have LS. Mon, 16 Jun 2025 04:00:00 Z https://www.yalemedicine.org/news/kidney-cancer-vaccine-shows-success-in-small-trial https://www.yalemedicine.org/news/kidney-cancer-vaccine-shows-success-in-small-trial Yale physician-scientist David Braun, MD, PhD, and a research team created personalized vaccines that kept patients cancer-free for about three years. Thu, 12 Jun 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-researchers-and-trainees-present-at-2025-asco-annual-meeting/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-researchers-and-trainees-present-at-2025-asco-annual-meeting/ Researchers from Yale Cancer Center participated in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30 to June 3, where they presented the latest research advancements from Yale Cancer Center and Smilow Cancer Hospital. Fri, 06 Jun 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/lymphoma-research-foundation-awards-dr-etienne-leveille-a-postdoctoral-fellowship-grant/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/lymphoma-research-foundation-awards-dr-etienne-leveille-a-postdoctoral-fellowship-grant/ Yale Cancer Center is pleased to announce that Etienne Leveille, MD, has been selected by the Lymphoma Research Foundation to receive a Postdoctoral Fellowship Grant. Wed, 04 Jun 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/national-cancer-research-month-with-dr-coraline-mlynarczyk/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/national-cancer-research-month-with-dr-coraline-mlynarczyk/ In honor of National Cancer Research Month, Dr. Coraline Mlynarczyk shares why her research is focused on cancer. Thu, 29 May 2025 12:30:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-experts-set-to-present-advances-in-cancer-research-at-the-worlds-largest-clinical-oncology-conference/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-experts-set-to-present-advances-in-cancer-research-at-the-worlds-largest-clinical-oncology-conference/ Over 40 Yale Cancer Center researchers will share advances for new therapies at the 2025 ASCO Annual Meeting with research areas covering breast, lung, prostate, head and neck, early onset, and metastatic cancers. Wed, 14 May 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/paradigm-shift-in-brain-cancer-research-needed-says-yale-professor/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/paradigm-shift-in-brain-cancer-research-needed-says-yale-professor/ Researchers need to find solutions differently than in the past to break through with treatments for aggressive brain cancers. Tue, 13 May 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/immunotherapy-balancing-cancer-treatment-benefits-and-risks/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/immunotherapy-balancing-cancer-treatment-benefits-and-risks/ Addressing serious side effects that can derail immunotherapy cancer treatments is the focus of research work at the Yale Cancer Center as well as clinical programs at Smilow Cancer Hospitals. Fri, 02 May 2025 11:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-research-presented-from-yale-cancer-center-at-aacr25/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-research-presented-from-yale-cancer-center-at-aacr25/ Yale Cancer Center faculty and trainees joined 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in Chicago for the 116th American Association for Cancer Research (AACR) annual meeting. Dr. Patricia LoRusso, Amy and Joseph Perella Professor of Medicine at Yale Cancer Center and AACR President for 2024-25, shared her global view on cancer. “Cancer is a global disease—it spares no continent, no country. And each patient that gets the disease deserves treatment.” Thu, 01 May 2025 12:00:00 Z https://research.google/blog/teaching-machines-the-language-of-biology-scaling-large-language-models-for-next-generation-single-cell-analysis/ https://research.google/blog/teaching-machines-the-language-of-biology-scaling-large-language-models-for-next-generation-single-cell-analysis/ C2S-Scale looks deep into how to best represent cells and biological information as text, opening up exciting applications for language-driven single-cell analysis with large language models. Thu, 17 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yales-post-ash-review-highlights-from-the-2024-american-society-of-hematology-annual-meeting/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yales-post-ash-review-highlights-from-the-2024-american-society-of-hematology-annual-meeting/ On March 28, 2025, members of the Hematology Program at Smilow Cancer Hospital gathered at Anthony’s Oceanview in New Haven, CT, to share information presented at the American Society of Hematology (ASH) Annual Meeting in December 2024. Mon, 31 Mar 2025 04:00:00 Z https://www.wfsb.com/2025/03/13/making-mark-local-vaccine-trial-taking-personal-approach-treating-kidney-cancer/ https://www.wfsb.com/2025/03/13/making-mark-local-vaccine-trial-taking-personal-approach-treating-kidney-cancer/ When it comes to treating and beating cancer, the same approach doesn’t always work for every patient. Fri, 14 Mar 2025 04:00:00 Z https://www.wtnh.com/news/health/therapeutic-vaccine-for-kidney-cancer-provided-positive-results-in-study/ https://www.wtnh.com/news/health/therapeutic-vaccine-for-kidney-cancer-provided-positive-results-in-study/ In Friday’s Health headlines, it’s kidney cancer awareness month. As we raise awareness about the disease, a new Yale-led study involving a personalized therapeutic vaccine provided positive results for patients. Dr. David Braun, a medical oncologist and researcher at Yale Cancer Center, joined WTNH's Good Morning Connecticut at 9 a.m. to discuss. Fri, 14 Mar 2025 04:00:00 Z https://ventures.yale.edu/news/blavatnik-fund-innovation-yale-support-15-breakthrough-interventions-cardiometabolic https://ventures.yale.edu/news/blavatnik-fund-innovation-yale-support-15-breakthrough-interventions-cardiometabolic This year’s awardees are tackling some of the most urgent life science challenges with projects spanning novel therapeutics to AI-powered medical solutions. Fri, 28 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/study-identifies-specific-immune-features-that-could-be-targeted-to-improve-cancer-treatment/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/study-identifies-specific-immune-features-that-could-be-targeted-to-improve-cancer-treatment/ Cancer Discovery Wed, 26 Feb 2025 14:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-2nd-annual-division-chiefs-and-promotions-dinner/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/yale-cancer-center-2nd-annual-division-chiefs-and-promotions-dinner/ Three Research Scientists and four Yale School of Medicine faculty of the Yale Cancer Center were celebrated in mid-February 2025 during a celebration in downtown New Haven. Wed, 26 Feb 2025 13:00:00 Z https://nypost.com/2025/02/26/health/new-kidney-cancer-vaccine-puts-9-patients-into-remission/ https://nypost.com/2025/02/26/health/new-kidney-cancer-vaccine-puts-9-patients-into-remission/ An early-phase trial found that a personalized vaccine targeted and destroyed cancer cells in nine patients with advanced kidney cancer, effectively wiping out the disease and keeping it at bay. Wed, 26 Feb 2025 05:00:00 Z https://nypost.com/2025/02/12/health/experimental-cancer-vaccine-shows-promising-results-for-certain-patients/ https://nypost.com/2025/02/12/health/experimental-cancer-vaccine-shows-promising-results-for-certain-patients/ Experimental vaccine reduced chances of kidney cancer recurrence. Thu, 13 Feb 2025 05:00:00 Z http://www.foxnews.com/health/new-cancer-vaccine-shows-promising-results-certain-patients http://www.foxnews.com/health/new-cancer-vaccine-shows-promising-results-certain-patients There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk. Wed, 12 Feb 2025 05:00:00 Z https://finance.yahoo.com/news/biontech-oncology-vaccine-trial-sees-124551283.html?guccounter=1 https://finance.yahoo.com/news/biontech-oncology-vaccine-trial-sees-124551283.html?guccounter=1 Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping cancer. Thu, 06 Feb 2025 05:00:00 Z https://www.healthday.com/health-news/cancer/therapeutic-vaccine-may-fight-advanced-kidney-cancer https://www.healthday.com/health-news/cancer/therapeutic-vaccine-may-fight-advanced-kidney-cancer The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their tumors, explained a team led by Dr. David Braun of the Yale Cancer Center in New Haven, Conn. Thu, 06 Feb 2025 05:00:00 Z https://www.forbes.com/sites/victoriaforster/2025/02/05/new-vaccine-shows-promise-for-kidney-cancer/ https://www.forbes.com/sites/victoriaforster/2025/02/05/new-vaccine-shows-promise-for-kidney-cancer/ “This approach is truly distinct from vaccine attempts in kidney cancer," said David A. Braun, MD, PhD first author of the paper in a press release. “We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively “steered” towards the cancer in a very specific way. We learned which specific targets in the cancer are most susceptible to immune attack and demonstrated that this approach can generate long-lasting immune responses, directing the immune system to recognize cancer,” added Braun. Thu, 06 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/personalized-therapeutic-vaccine-steers-the-immune-system-to-fight-kidney-cancer/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/personalized-therapeutic-vaccine-steers-the-immune-system-to-fight-kidney-cancer/ Vaccines are on the cutting edge of cancer therapy research as a possible treatment option for the future. The trial led by Yale Cancer Center (YCC) principal investigator and first author David Braun, MD, PhD, explored the effectiveness of the personalized cancer vaccine specifically for patients with advanced kidney cancer — stage III or IV clear cell renal cell carcinoma. Wed, 05 Feb 2025 16:00:00 Z https://www.statnews.com/2025/02/05/personalized-cancer-vaccine-kidney-dana-farber-yale/ https://www.statnews.com/2025/02/05/personalized-cancer-vaccine-kidney-dana-farber-yale/ In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines. Wed, 05 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-study-unveils-clues-to-exceptional-response-in-metastatic-kidney-cancer-immunotherapy/ https://websites4-live-prod.ysmdevs.com/cancer/news-article/new-study-unveils-clues-to-exceptional-response-in-metastatic-kidney-cancer-immunotherapy/ Yale Cancer Center researchers uncovered factors behind why some patients may respond better to certain immunotherapy treatments. Thu, 09 Jan 2025 10:00:00 Z